Shanghai Junshi Biosciences Co., Ltd. (Stock code: 1877) announced the completion of its 2026 first tranche of technology innovation bonds. According to the announcement, the company issued RMB1 billion in bonds with a 3+2-year term, maturing on 26 January 2031, and carrying an issuance interest rate of 2.70%.

The board of directors noted that Shanghai Junshi Biosciences received the funds on 26 January 2026 following acceptance of registration for the medium term notes by the national association of financial market institutional investors. The announcement advises shareholders and potential investors to exercise caution when dealing in the company’s securities.